WealthPLAN Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15
| Closed | -$10.4K | – | 348 |
|
|
2023
Q3 | $10.4K | Buy |
15
+2
| +15% | +$1.39K | ﹤0.01% | 314 |
|
|
2023
Q2 | $60.3K | Sell |
13
-6
| -32% | -$27.9K | 0.01% | 480 |
|
|
2023
Q1 | $50.9K | Sell |
19
-1
| -5% | -$2.68K | 0.01% | 551 |
|
|
2022
Q4 | $55.1K | Buy |
+20
| New | +$55.1K | ﹤0.01% | 387 |
|
|
2022
Q1 | $33K | Hold |
14
| – | – | ﹤0.01% | 379 |
|
|
2021
Q4 | $60K | Buy |
14
+2
| +17% | +$8.57K | ﹤0.01% | 374 |
|
|
2021
Q3 | $84K | Buy |
12
+3
| +33% | +$21K | 0.01% | 368 |
|
|
2021
Q2 | $78K | Buy |
9
+4
| +80% | +$34.7K | 0.01% | 352 |
|
|
2021
Q1 | $117K | Hold |
5
| – | – | 0.01% | 327 |
|
|
2020
Q4 | $57K | Hold |
5
| – | – | ﹤0.01% | 329 |
|
|
2020
Q3 | $18K | Hold |
5
| – | – | ﹤0.01% | 310 |
|
|
2020
Q2 | $21K | Hold |
5
| – | – | ﹤0.01% | 305 |
|
|
2020
Q1 | $15K | Hold |
5
| – | – | ﹤0.01% | 250 |
|
|
2019
Q4 | $16K | Hold |
5
| – | – | ﹤0.01% | 246 |
|
|
2019
Q3 | $14K | Buy |
5
+2
| +67% | +$5.6K | ﹤0.01% | 232 |
|
|
2019
Q2 | $17K | Buy |
+3
| New | +$17K | ﹤0.01% | 236 |
|